The statutory obligations of NHSBT with respect to organ donation and transplantation are set out in the Directions. The Solid Organ Advisory Groups (SOAGs) play a highly valued and essential role in providing NHSBT with the necessary clinical advice on organ donation and transplantation. In addition, they work with NHSBT and other organisations to increase the quality and number of solid organ transplants in the UK.
Although the major role of the Solid Organ Advisory Groups is to advise NHSBT to help promote all aspects of organ transplantation and ensure equity of access to transplant and optimal patient outcomes, it is recognised that the SOAGs provide a much broader resource to help promote deceased and living organ donation and transplantation in the UK and internationally, and to provide a unique forum for all those involved in organ transplantation in the UK to meet and to discuss and promote evidence based improvements in patient outcomes.
The work of the SOAGs is integral to organ donation and transplantation: the SOAGs are integrated into the structure of the Directorate of Organ Donation and Transplantation (ODT) through the Chairs of the Advisory Groups Committee and to the Senior Management Team of ODT. Policies relating to organ donation, patient selection for transplant listing and transplantation are reviewed and agreed by the Transplant Policy Review Committee (TPRC) on behalf of the NHSBT Board. The Advisory Group Chairs are members of the TPRC.
CARDIOTHORACIC ADVISORY GROUP (CTAG)
TERMS OF REFERENCE
Advisory Group
The Cardiothoracic Advisory Group will comprise of two sections:
- One section to advise on issues related to heart transplantation
- One section to advise on issues related to lung transplantation
Membership
Chair:
Appointment: applications will be invited from transplant health care professionals (see person specification in Appendix 1). The Chair will be appointed by NHSBT through a formal appointment committee with a panel of at least three people and will include the Associate Medical Director (AMD) of ODT and the President (or nominee) of the British Transplantation Society.
The AMD will develop the Job Plan and Person Specification for the Chair
Tenure:
- The Chair will be appointed for 3 years
- The Chair may apply and be re-appointed for a second and final two year-term
- A person who has been Chair may re-apply at any date more than three years after standing down
Remuneration: The Chair will receive a Special Duty Payment allow them to devote time to carry out their duties.
Appraisal: The Chair will meet the AMD of ODT annually for a formal review of progress made and to agree future work plans and associated targets.
The role of the Chair will include:
- Chairing the twice-yearly meetings of the Heart Advisory Group and the Lung Advisory Group
- Chairing the meetings of the Cardiothoracic Centre Directors
- Attending bi-annual meetings with patient/lay members
- Attending the meetings of the National Retrieval Group
- Attending the meetings of the Advisory Group Chairs Committee
- Chairing the CTAG Adjudication Panel, as described in POL229 (Heart Patient Selection Policy) and POL231 (Lung Patient Selection Policy)
- Helping the AMD of ODT assess response to signals from outcomes monitoring
- Providing ad hoc advice to ODT
Where appropriate, the Chair may nominate a Deputy to attend meetings on behalf of the Chair; the nominated Deputy will have the full authority of the Chair.
Membership of the Hearts and Lungs Advisory Groups
Membership of the Hearts and lungs Advisory Groups will include:
Voting members
- Chair
- One Physician representative from each designated cardiothoracic transplant centre
- One Surgeon representative from each designated cardiothoracic transplant centre
- Two Lay Member representatives
- One Transplant Centre manager
Non-voting members
- One representative from each of the Commissioning groups for the four UK nations
- One representative from each of the national Departments of Health
- One representative nominated by the British Transplantation Society Director of Organ Donation and Transplantation (ODT)
- Associate Medical Director ODT
- Relevant NHSBT Statistician
- Associate Director of Statistics and Clinical Studies / Head of Organ Donation and Transplantation Studies
- ODT Scientific Advisor
- National Clinical Leads for:
- Retrieval
- Governance
- Living Donation
- Organ Donation
- Organ Donation Services Team representative
- Recipient Co-Ordinator representative
- Other members co-opted by the Group (may include representatives from relevant professional bodies, societies and colleges)
- The Chair, in discussion with members of the Group, may include other appropriate members
Representatives from the Republic of Ireland will be welcome as observers (unless selection and allocation is shared between UK and Ireland).
Members will be responsible for
- Bringing to the Advisory Group any relevant concerns or suggestions from the centres they represent: where possible this should be in writing so that the paper can be circulated prior to the meeting
- Circulating minutes and other discussion items and items of relevance within their organisations (to clinicians, managers and other relevant parties)
- Responding to relevant items on the Agenda
- The Chair will appoint a Deputy Chair from the CTAG (Heart) Group and a Deputy Chair from the CTAG (Lung) Group
- If there is more than one applicant, the candidates will be interviewed by the Chair and NHSBT representatives
- The Deputy Chair will assume the role and duties of the Chair when the Chair is unavailable, when there are possible conflicts of interest or at the request of the Chair
- On occasions when the Deputy Chair assumes the chairing role, it would be appropriate for their centre to be represented by another centre representative
- Each Deputy Chair will be appointed for the period of the Chair’s tenure
- When a Deputy Chair ceases to be the CTAG Group representative for their own transplant centre, they will also demit from being Deputy Chair
- The representative(s) from each transplant centre will be determined by the Centre Director(s) in collaboration with senior clinicians in their centre(s) who will also agree the tenure for each representative’s membership
- Members unable to attend should send a deputy who will have the same voting rights as the member
- Members will be expected to attend at least 80% of the meetings
- The Minutes will record membership attendance
- The Transplant Managers Forum will agree the Transplant Manager who will be appointed for four years
- Patient/lay representatives will be appointed through an independent process for a four-year term
Role of the Cardiothoracic Advisory Group
The role of the Advisory Group will be to provide a forum whereby clinicians and other interested parties (including commissioners, regulators and non-clinical stakeholders) can work with NHSBT and other organisations to improve the number and quality of organs donated and transplanted; and improve the outcome of patients awaiting and following transplantation.
Delivery of this aim will include:
- Agree a rolling two-year work plan and review progress annually
- Agree membership of Working Groups as required with additional expertise co-opted as required (it is not necessary that members of the Working Group are all members of the Advisory Group)
- Task the Working Group to investigate and report on specific issues in a given time frame
- Review, approve or amend recommendations from the Working Group
- Review relevant current guidelines and policies at least annually and advise NHSBT on operational aspects of transplantation including:
- Organ retrieval
- Recipient selection criteria
- Organ allocation schemes
- Organ offering
- Transplant activity and outcome
- Recommend, as necessary, promote and implement changes to the nationally agreed protocols
- Advise NHSBT and other bodies on appropriate risk factors and context for outcome monitoring and interpretation of findings
- Monitor and report on clinical governance with especial reference to outcomes and deviations from expected outcome
- Monitor deviation from agreed protocols in selection and/or allocation
- Ensure equity of access of patients to transplantation throughout the UK
- Evaluate and comment on issues raised by investigations into triggers from outcomes analysis, investigations and other issues
- Identify and promote areas of audit and research
- Remit to ODT matters of practice or policy that require consideration within a broader framework.
- Liaise as necessary with the British Transplantation Society and other professional bodies in the development of national standards
- Provide six-monthly reports of clinical governance
- Respond to, advise on, or support implementation aspects of organ donation and transplantation policy that arise from legal and/or policy developments both within the UK and more widely
- Co-ordinate a programme of peer review (with other appropriate bodies)
Reporting
The CTAG will report to Senior Management Team of ODT
Voting
If an agreement cannot be reached by consensus, a vote will be taken of the voting members; a majority will be binding. The Chair will have a casting vote but will not take part in the initial vote
Where a consensus is not reached on policies, the Chair must ensure that the Chair of the Transplant Policy Review Committee is informed of the centres and the nature of concerns of those who did not support the policy
Frequency of Meetings
- The CTAG Advisory Group will meet at least twice a year at a venue to be agreed
- The CTAG Advisory Group meeting will be in two parts:
- One part is for the CTAG Hearts section members to discuss matters pertaining to heart transplantation
- One part is for the CTAG Lungs section members to discuss matters pertaining to lung transplantation
CTAG Centre Directors Group
- The Chair of the Advisory Group, or deputy, will chair the Unit Directors Group.
- Membership of the Group will comprise of:
- The Clinical Directors, or deputy, of each of the Cardiothoracic Transplant Centre
- The relevant statistical lead
- The group will meet between the CTAG Advisory Group meetings by telecon as agreed by the group.
- The main roles of the group are to:
- Monitor the progress of tasks as required by the Advisory Group and report back to that Group. Review performance of centres to identify outliers, suggest corrective action and improvements to working practice and monitor implementation
CTAG Clinical Audit Group
- The main role of the CTAG Clinical Audit Group is to oversee specific audit projects as required by the Advisory Group and to advise NHSBT on data collection and audit. The CTAG Clinical Audit Group will meet every quarter at a venue/by telecon as agreed by the Group.
- The Chair of the Cardiothoracic Advisory Group will chair the CTAG Clinical Audit Group; but may devolve this responsibility to another member of the Advisory Group
- The membership of the CTAG Clinical Audit Group will be selected by the voting members of CTAG, representing:
- heart transplantation
- lung transplantation
- paediatric cardiothoracic transplantation
- donor organ retrieval
- mechanical circulatory support
- the relevant statistical lead
- specialist nurse/transplant coordinator
- Members of the Clinical Audit Group are expected to attend at least 80% of the meetings
- Members of the Clinical Audit Group will not act as representatives of their own centre
- The Clinical Audit Group may invite other members of NHSBT and others as required
- The Clinical Audit Group will also, on behalf of the Advisory Group, assess applications for access to data for research and advise statisticians as required
Working Group
- It is anticipated that the Advisory Groups will have Working Groups to address specific aspects of transplantation or issues; the nature, membership, frequency, lifetime and venue of these meetings will be at the discretion of the Advisory Group. Teleconference work is encouraged
- The Chair of the Advisory Group, or nominated deputy, will chair the Working Group
- Members of the Working Group are expected to attend at least 80% of the meetings
- Members of the Working Group will not act as representatives of their own centre
- Members unable to attend may nominate a Deputy who will have the same rights as the member
- The relevant statistical lead will attend as a non-voting member.
- The Working Group may invite other members of NHSBT and others as required to consider specific topics
Patient Group Meetings
- The Chair will attend and (when required Co-Chair) 6 monthly meetings of the Cardiothoracic Patient Group. Stakeholders include representatives from the designated transplant centres as well as associated organisations and charity groups.
Minutes and publication of papers on the ODT website
The Minutes of each meeting will be taken by the NHSBT (ODT) Secretariat.
Publication of Minutes and Papers
- The Agenda, Papers and agreed Minutes of the Advisory Group meetings will be published on the ODT website
- The Agenda, Minutes and papers of the Stakeholders’ Meeting will be published on the ODT website
- Meeting papers for the working groups will not be published as these will be work in progress, although reports to the Advisory Group will be included in the minutes of the Advisory Group Meeting
- The Agenda and Papers will be published on the ODT website when these are circulated to members of CTAG. Minutes will be published after they have been approved
- Redacted papers will be published only if the originals contain patient-identifiable material, commercially sensitive or published details would preclude publication in a peer-reviewed journal
- Minutes will be circulated electronically
Support
Budget
CTAG will be allocated an agreed budget, administered by NHSBT, which will include travel expenses, hosting of meetings, working parties, consensus meetings and other relevant activities. Accountability for the budget will be with the Chair of CTAG but the budget will be held within ODT.
Statistical and analytical support
CTAG will be allocated an agreed level of support from the Department of Statistics and Clinical Studies to support the activities of CTAG: this support will be used for analysis of outcomes, audit, governance issues, service evaluation, modelling of alternative methods of service delivery and other projects, agreed with the Chair of the Advisory Group, the Assistant Director, Statistics and Clinical Studies / Head of ODT Studies and the Associate Medical Director ODT
- The Chair of CTAG, Assistant Director, Statistics and Clinical Studies / Head of ODT Studies and Associate Medical Director will meet at least every six months to agree the agenda, new projects and assign priorities
- The statistical lead will prepare and circulate at each Advisory Group meeting an outline of projects agreed and estimated completion dates
Administrative support
The Clinical & Support Services section of ODT will provide an agreed level of administrative support, to help with the planning and organisation of meetings, minute taking and other relevant matters.
Appendix 1
Person Specification for Chair of a solid Organ Advisory Group
The Chair will:
- Be currently active in the relevant field of solid organ transplantation
- Have a knowledge of donation and transplantation both in the UK and internationally
- Be registered with the General Medical Council
- Have a substantive or honorary Clinical Contract at Consultant status with a Hospital/Trust/Board within the UK
- Have at least 5 years’ experience in organ transplantation at a Consultant level (or equivalent)
- Have the support of the clinicians and scientists in the relevant field of transplantation
- Have support from his/her employer to devote the necessary time to act as Chair
- Able to devote sufficient time to fulfil the role